Suggestions
Claude Bertrand
Executive Vice President R&D
Claude Bertrand is a prominent figure in the pharmaceutical industry, currently serving as the Executive Vice President of Research and Development and Chief Scientific Officer at Servier, a leading independent pharmaceutical company.13
Professional Background
Claude Bertrand joined Servier in 2017 as Executive Director R&D and Chief Scientific Officer. In 2018, he was appointed to the Group's Executive Committee.3 As a member of the Executive Committee, he plays a crucial role in implementing the Group's strategy and overseeing operational performance.1
Responsibilities
In his position, Dr. Bertrand is responsible for:
- Leading Servier's research and development efforts
- Overseeing the company's scientific strategy
- Contributing to the implementation of the Group's overall strategy
Language Skills
Claude Bertrand is proficient in both French and English:
- French: Native or bilingual proficiency
- English: Full professional proficiency2
Location and Network
Dr. Bertrand is based in Le Vésinet, Île-de-France, France. He has a substantial professional network, with over 500 connections on LinkedIn.2
Industry Recognition
Claude Bertrand is recognized as a leader in pharmaceutical innovation. He frequently participates in industry events and discussions, sharing insights on topics such as Servier's R&D strategy and the challenges of AI in the pharmaceutical industry.5
His expertise and leadership in the field have led to additional roles, such as being appointed as an independent board member for MaaT Pharma, further demonstrating his influence in the pharmaceutical and biotech sectors.4
Highlights
🏃♀️Le 29 septembre prochain, nous courons solidaire à Saint-Cloud pour la 13ème édition de Imagine for Margo - Children without Cancer, Enfants sans cancer (www.enfantsanscancer.com). 100% des dons seront reversés pour la recherche. Venez marcher ou courir avec nous et/ou aidez-nous à collecter des fonds pour la recherche et pour les enfants (lien ci-dessous). Merci d'avance pour votre soutien. Claude
🚀 Very PROUD and HONORED to have participated to the FIRST Golden Ticket campaign in France for start-ups to integrate Spartners! Spartners is a cutting-edge accelerator dedicated to therapeutic innovation, created by Servier, operated by BioLabs France in the premises of the Servier R&D Institute in Paris-Saclay.
We had 4 finalists in this Saclay 2024 campaign and they were all great at pitching their start-ups!👍
Thanks to the jury members for their excellent work: Christophe Thurieau, Marta Garcia Manrique, Laure SAVARIN, Raphael R. Steimbach, Johanna Michielin, Julien ELRIC
👏 Congratulations to kyron.bio which is the winner! Well done Emilia McLaughlin!🤩 😀 The prize grants the winning start-up a close support from Servier's experienced teams, and free access to the incubator's shared facilities and numerous programs and services. This year, we already awarded three Golden Tickets to support promising companies and entrepreneurs in the life sciences sector in the United States. At Servier, we believe that by adopting an open, transparent and transversal approach to innovation , we can discover and develop transformative therapeutic solutions that meet patients' needs. That's why we are multiplying diverse initiatives with start-ups and biotech companies with a single objective: to stimulate scientific innovation with and for patients. #WeAreServier #R&D #Innovation #Startup #ParisSaclay
